Jazz Pharmaceuticals plc (JAZZ)
NASDAQ · Healthcare
Jazz Pharmaceuticals plc Shareholder Equity 2009–2025
Jazz Pharmaceuticals plc annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Jazz Pharmaceuticals plc shareholder equity as of December 31, 2025: 4.32B, a 5.49% increase year-over-year.
- Jazz Pharmaceuticals plc shareholder equity for 2025 were 4.32B, a 5.49% increase from 2024.
- Jazz Pharmaceuticals plc shareholder equity for 2024 were 4.09B, a 9.55% increase from 2023.
- Jazz Pharmaceuticals plc shareholder equity for 2023 were 3.74B, a 21.11% increase from 2022.
- Jazz Pharmaceuticals plc shareholder equity for 2022 were 3.09B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Jazz Pharmaceuticals plc Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $4,319 |
| 2024 | $4,094 |
| 2023 | $3,737 |
| 2022 | $3,086 |
| 2021 | $3,965 |
| 2020 | $3,660 |
| 2019 | $3,111 |
| 2018 | $2,757 |
| 2017 | $2,713 |
| 2016 | $1,877 |
| 2015 | $1,706 |
| 2014 | $1,371 |
| 2013 | $1,296 |
| 2012 | $1,121 |
| 2011 | $193 |
Jazz Pharmaceuticals plc Shareholder Equity — FAQ
Jazz Pharmaceuticals plc (JAZZ) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see JAZZ's shareholder equity history?
The chart and table above show Jazz Pharmaceuticals plc's shareholder equity by year and by quarter, including the growth rate.